COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world study
Abstract Background Coronavirus disease 2019 (COVID-19) vaccine has played a major role in ending the pandemic. However, little is known about the influence of COVID-19 vaccine on the efficacy of immunotherapy in patients with non-small cell lung cancer (NSCLC). Objectives The goal of this study is...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2023-09-01
|
| Colección: | Infectious Agents and Cancer |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13027-023-00526-7 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|